Cannabinoids for the Treatment of Dermatologic Conditions

Keyphrases

• Cannabinoids 100%
• Dermatological Diseases 100%
• Inflammatory Skin Diseases 100%
• Literature Search 50%
• Clinical Practice Guidelines 50%
• Long-term Treatment 50%
• Epidermolysis Bullosa 50%
• Cannabidiol 50%
• Cannabinoid Receptor 2 50%
• Diffuse Cutaneous Systemic Sclerosis 50%
• Dermatomyositis 50%
• Pharmacologic 50%
• Anti-inflammatory Properties 50%
• Embase 50%
• PubMed 50%
• Conventional Therapy 50%
• Sublingual 50%
• Trichotillomania 50%
• Dronabinol 50%
• Δ9-tetrahydrocannabinol (Δ9-THC) 50%
• Autoimmune Skin Disorders 50%

Medicine and Dentistry

• Dermatosis 100%
• Cannabinoid 100%
• Dermatological Agent 100%
• Clinician 50%
• Systemic Scleroderma 50%
• Epidermolysis bullosa 50%
• Anti-Inflammatory Drug 50%
• Dermatomyositis 50%
• Dronabinol 50%
• Cannabinoid Receptor 50%
• Tetrahydrocannabinol 50%
• Trichotillomania 50%
• Cannabidiol 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Cannabinoid 100%
• Skin Disease 100%
• Dermatological Agent 100%
• Cannabidiol 50%
• Anti-Inflammatory Drug 50%
• Tetrahydrocannabinol 50%
• Systemic Sclerosis 50%
• Dronabinol 50%
• Cannabinoid Receptor 50%
• Trichotillomania 50%
• Dermatomyositis 50%
• Epidermolysis bullosa 50%